Company Filing History:
Years Active: 2025
Title: Innovations of Bryan Daniel Ellis in Cancer Treatment
Introduction
Bryan Daniel Ellis is an accomplished inventor based in Denver, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of HER2 mutation inhibitors. His work focuses on creating compounds that can aid in the treatment of abnormal cell growth, including cancer.
Latest Patents
Bryan Daniel Ellis holds a patent for HER2 mutation inhibitors. This invention relates to compounds of Formula (I) and enantiomers thereof, as well as pharmaceutically acceptable salts of these compounds. The invention further encompasses pharmaceutical compositions that include such compounds and salts, along with methods and uses for treating abnormal cell growth in subjects in need.
Career Highlights
Ellis is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development aimed at advancing cancer treatment options. With a focus on innovative solutions, he has dedicated his career to improving patient outcomes through scientific discovery.
Collaborations
Some of his notable coworkers include Erik James Hicken and Ellen Ruth Laird. Their collaborative efforts contribute to the ongoing research and development initiatives at Pfizer Corporation.
Conclusion
Bryan Daniel Ellis exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the fight against cancer. His work on HER2 mutation inhibitors showcases the potential of scientific advancements to transform treatment options for patients.